Masato Abei

2.6k total citations
66 papers, 2.0k citations indexed

About

Masato Abei is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Masato Abei has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 27 papers in Hepatology and 17 papers in Oncology. Recurrent topics in Masato Abei's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (13 papers). Masato Abei is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (13 papers). Masato Abei collaborates with scholars based in Japan, United States and Taiwan. Masato Abei's co-authors include Junichi Shoda, Kuniaki Fukuda, Masashi Mizumoto, Naomi Tanaka, Koichi Tokuuye, Shinji Sugahara, Koji Tsuboi, Hidetsugu Nakayama, Nobuyoshi Fukumitsu and Hideyuki Sakurai and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Masato Abei

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masato Abei Japan 23 1.0k 784 629 439 386 66 2.0k
Sang‐Hue Yen Taiwan 23 444 0.4× 315 0.4× 436 0.7× 352 0.8× 512 1.3× 52 1.8k
Delia D’Avola Spain 25 1.2k 1.2× 326 0.4× 726 1.2× 489 1.1× 407 1.1× 60 2.1k
Marie‐Pierre Bralet France 22 710 0.7× 404 0.5× 438 0.7× 814 1.9× 675 1.7× 46 2.2k
Tom M. Ganten Germany 23 471 0.5× 193 0.2× 452 0.7× 215 0.5× 414 1.1× 68 2.0k
Manabu Morimoto Japan 33 2.1k 2.0× 636 0.8× 1.2k 1.9× 770 1.8× 624 1.6× 171 3.3k
Takuma Teratani Japan 23 3.0k 2.9× 510 0.7× 2.0k 3.1× 952 2.2× 477 1.2× 59 3.6k
Masaaki Kondo Japan 24 733 0.7× 237 0.3× 487 0.8× 434 1.0× 318 0.8× 91 1.6k
Yukio Nakajima Japan 14 2.2k 2.1× 427 0.5× 1.3k 2.0× 1.0k 2.4× 469 1.2× 19 2.9k
Xiao-Jun Lin China 16 2.2k 2.2× 417 0.5× 1.3k 2.1× 960 2.2× 437 1.1× 24 2.6k
Hobyung Chung Japan 33 2.7k 2.7× 331 0.4× 2.0k 3.1× 665 1.5× 334 0.9× 77 3.3k

Countries citing papers authored by Masato Abei

Since Specialization
Citations

This map shows the geographic impact of Masato Abei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Abei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Abei more than expected).

Fields of papers citing papers by Masato Abei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Abei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Abei. The network helps show where Masato Abei may publish in the future.

Co-authorship network of co-authors of Masato Abei

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Abei. A scholar is included among the top collaborators of Masato Abei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Abei. Masato Abei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemay, Chantal G., Brian A. Keller, Robert E. Edge, Masato Abei, & John C. Bell. (2018). Oncolytic Viruses: The Best is Yet to Come. Current Cancer Drug Targets. 18(2). 109–123. 16 indexed citations
2.
Oshiro, Yoshiko, Masashi Mizumoto, Toshiyuki Okumura, et al.. (2017). Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma. Radiotherapy and Oncology. 123(2). 240–245. 40 indexed citations
3.
Endo, Shinji, et al.. (2014). Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation. PLoS ONE. 9(7). e102831–e102831. 33 indexed citations
4.
Suzuki, Yoshiharu, Masato Homma, Masato Abei, Ichinosuke Hyodo, & Yukinao Kohda. (2013). Effects of Dipyridamole Coadministration on the Pharmacokinetics of Ribavirin in Healthy Volunteers. Drug Metabolism and Pharmacokinetics. 28(5). 406–410. 2 indexed citations
5.
Mizumoto, Masashi, Toshiyuki Okumura, Takayuki Hashimoto, et al.. (2012). Evaluation of Liver Function After Proton Beam Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 82(3). e529–e535. 54 indexed citations
6.
Nakayama, Hidetsugu, Shinji Sugahara, Kuniaki Fukuda, et al.. (2011). Proton Beam Therapy for Hepatocellular Carcinoma Located Adjacent to the Alimentary Tract. International Journal of Radiation Oncology*Biology*Physics. 80(4). 992–995. 42 indexed citations
7.
Fukumitsu, Nobuyoshi, Takayuki Hashimoto, Toshiyuki Okumura, et al.. (2011). Investigation of the Geometric Accuracy of Proton Beam Irradiation in the Liver. International Journal of Radiation Oncology*Biology*Physics. 82(2). 826–833. 15 indexed citations
8.
Endo, Shinji, Kenji Yamato, Toshikazu Moriwaki, et al.. (2010). Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin‐3 in gastric cancer cells. Cancer Science. 102(3). 605–613. 49 indexed citations
9.
Mizumoto, Masashi, Toshiyuki Okumura, Takayuki Hashimoto, et al.. (2010). Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1039–1045. 129 indexed citations
10.
Sugahara, Shinji, Yoshiko Oshiro, Hidetsugu Nakayama, et al.. (2009). Proton Beam Therapy for Large Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 76(2). 460–466. 98 indexed citations
11.
Nakayama, Hidetsugu, Shinji Sugahara, Mari Tokita, et al.. (2009). Proton beam therapy for hepatocellular carcinoma. Cancer. 115(23). 5499–5506. 88 indexed citations
12.
Sugahara, Shinji, Hidetsugu Nakayama, Kuniaki Fukuda, et al.. (2009). Proton-Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis*. Strahlentherapie und Onkologie. 185(12). 782–788. 84 indexed citations
13.
Fukuda, Kuniaki, Masato Abei, Hideyo Ugai, et al.. (2008). E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer. Cancer Gene Therapy. 16(2). 126–136. 16 indexed citations
14.
Hata, Masaharu, Koichi Tokuuye, Shinji Sugahara, et al.. (2007). Proton Beam Therapy for Aged Patients With Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 69(3). 805–812. 40 indexed citations
15.
Kojima, Hideo, Masato Abei, Nobuyuki Takei, et al.. (2002). Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis. European Journal Of Haematology. 69(2). 101–104. 11 indexed citations
16.
Abei, Masato, Takashi Yamaguchi, Yasushi Matsuzaki, et al.. (1999). Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis. Hepatology. 30(1). 6–13. 88 indexed citations
17.
Tanaka, Einosuke, Akio Ishikawa, Masato Abei, & Shinichi Kobayashi. (1996). Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 115(3). 211–216. 4 indexed citations
18.
Abei, Masato, Naomi Tanaka, Hisashi Matsumoto, et al.. (1993). Laparoscopic observation of liver colored with indocyanine green in chronic hepatitis. I. Improved sensitivity for diagnosis of fibrosis. Gastrointestinal Endoscopy. 39(3). 406–409. 1 indexed citations
19.
Abei, Masato, Naomi Tanaka, Hisashi Matsumoto, Yasushi Matsuzaki, & Toshiaki Osuga. (1993). Laparoscopic observation of liver colored with indocyanine green in chronic hepatitis. II. Correlation with subcapsular ligandin. Gastrointestinal Endoscopy. 39(3). 410–412. 1 indexed citations
20.
Abei, Masato, Naomi Tanaka, Hisashi Matsumoto, Yasushi Matsuzaki, & Toshiaki Osuga. (1989). Evaluation of peritoneoscopic view of liver colored with indocyanine green by aimed biopsy.. Kanzo. 30(11). 1639–1640. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang‐Hue Yen Breakdown of academic impact, for papers by Delia D’Avola Breakdown of academic impact, for papers by Marie‐Pierre Bralet Breakdown of academic impact, for papers by Tom M. Ganten Breakdown of academic impact, for papers by Manabu Morimoto Breakdown of academic impact, for papers by Takuma Teratani Breakdown of academic impact, for papers by Masaaki Kondo Breakdown of academic impact, for papers by Yukio Nakajima Breakdown of academic impact, for papers by Xiao-Jun Lin Breakdown of academic impact, for papers by Hobyung Chung
Rankless by CCL
2026